Tenofovir to Prevent Perinatal Transmission of Hepatitis B
- PMID: 29897855
- PMCID: PMC8628567
- DOI: 10.1056/NEJMc1805396
Tenofovir to Prevent Perinatal Transmission of Hepatitis B
Conflict of interest statement
Since publication of their article, the authors report no further potential conflict of interest.
Comment on
-
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.N Engl J Med. 2018 Jun 14;378(24):2348-9. doi: 10.1056/NEJMc1805396. N Engl J Med. 2018. PMID: 29900725 No abstract available.
-
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.N Engl J Med. 2018 Jun 14;378(24):2349. doi: 10.1056/NEJMc1805396. N Engl J Med. 2018. PMID: 29900726 No abstract available.
-
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.N Engl J Med. 2018 Jun 14;378(24):2349-50. doi: 10.1056/NEJMc1805396. N Engl J Med. 2018. PMID: 29900727 No abstract available.
References
-
- Han G-R, Cao M-K, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55:1215–21. - PubMed
-
- Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016;374:2324–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources